Rate of palivizumab administration in accordance with current recommendations among hospitalized children

The American Academy of Pediatrics recommends palivizumab prophylaxis for children born premature or with chronic lung disease to reduce the severity of respiratory syncytial virus (RSV) infection. The purpose of the current study is to examine palivizumab administration among children hospitalized with RSV infection. This is a retrospective medical record review at a tertiary care children's hospital. The study included children